Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$74.8K
3.75K shares
SULLIVAN CHRISTOPHER RYAN plans to sell 3.75K shares of AVALO THERAPEUTICS, INC. valued at approximately $74.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Options Under a Registered Plan
Services Rendered
Shares Purchased Through Employee Stock Purchase Plan
Compensation
Shares Purchased Through Employee Stock Purchase Plan
Compensation
Shares Purchased Through Employee Stock Purchase Plan
Compensation
Shares Purchased Through Employee Stock Purchase Plan
Compensation
Shares Purchased Through Employee Stock Purchase Plan
Compensation
Shares Purchased Through Employee Stock Purchase Plan
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/17/2026 | Exercise of Options Under a Registered Plan Services Rendered | 2.88K | — |
6/10/2026 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 450.00 | — |
12/10/2025 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 417.00 | — |
6/9/2023 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 1.00 | — |
12/10/2021 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 1.00 | — |
12/10/2020 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 2.00 | — |
6/10/2020 | Shares Purchased Through Employee Stock Purchase Plan Compensation | 2.00 | — |
| Total | 3.75K | ||
Units to sell
3.75K
Market value
$74.8K
Units
3.75K
Value
$74.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 3.75K | $74.8K | NASDAQ | Planned |
| Total | 3.75K | $74.8K | ||